Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic Intracranial Hypertension.

Robert K. Shin1, Laura J. Balcer

  • 1*Department of Neurology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. lbalcer@mail.med.upenn.edu

Current Treatment Options in Neurology
|May 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Giant Cell Arteritis.

Current treatment options in neurology·2003
Same author

Optic Neuritis.

Current treatment options in neurology·2001
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Idiopathic intracranial hypertension (IIH), or pseudotumor cerebri, is a vision-threatening condition. Management includes weight loss, medication review, and treatments like acetazolamide, surgery, or bariatric procedures for obese patients.

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, poses a significant risk to vision.
  • Close monitoring of visual acuity, visual fields, and fundus appearance is crucial for all IIH patients.

Purpose of the Study:

  • To outline current management strategies for idiopathic intracranial hypertension.
  • To emphasize the importance of multidisciplinary care and tailored treatment approaches.

Main Methods:

  • Review of existing literature and clinical guidelines for IIH management.
  • Discussion of pharmacological, surgical, and lifestyle interventions.

Main Results:

  • Weight loss is recommended for obese patients with IIH.

Related Experiment Videos

  • Medications potentially causing or worsening IIH should be discontinued.
  • Acetazolamide is a first-line treatment for symptomatic patients or those with vision loss; furosemide may be a second-line option.
  • Surgical interventions like optic nerve sheath fenestration or lumboperitoneal shunting are considered for progressive vision loss or refractory symptoms.
  • Bariatric surgery offers a long-term solution for severely obese patients but is not for acute management.

    • Conclusions:

    • Effective management of IIH requires a comprehensive approach, including lifestyle modifications, pharmacotherapy, and potentially surgical intervention.
    • Treatment decisions should be individualized based on symptom severity, vision status, and patient-specific factors.
    • Special considerations are necessary for pediatric and pregnant populations with IIH.